You have 0 free disease views remaining today. Register for more view, it is 100% free →
Friedreich ataxia 2
ICD-10 Codes
Related ICD-10:
Description
Friedreich Ataxia: A Rare Genetic Condition
Friedreich ataxia (FA) is a rare genetic condition that causes progressive nervous system damage and movement issues [2]. It is characterized by the degeneration of the nerve tissues in the spinal cord, leading to symptoms such as:
- Poor balance: People with FA often experience difficulty maintaining their balance, especially in dark conditions [4].
- Unsteadiness while walking: Walking becomes increasingly difficult due to impaired muscle coordination and gross motor skills [4].
- Slurred speech: Speech difficulties are a common symptom of FA, making it hard for individuals to communicate effectively [4].
FA is an autosomal recessive inherited disorder caused by mutations in the FXN gene [10]. This genetic condition primarily affects the nervous system and can also impact the heart. The symptoms of FA typically begin between 10 and 15 years of age, although they can start earlier or later in life [3].
Overall, Friedreich ataxia is a complex condition that requires ongoing medical attention to manage its symptoms and slow disease progression.
References:
[1] Not provided (initial query) [2] Context result 2 [3] Context result 3 [4] Context result 4 [10] Context result 10
Signs and Symptoms
Symptoms of Friedreich’s Ataxia
Friedreich’s ataxia (FRDA) is a genetic condition that affects the nervous system, causing progressive damage to the spinal cord, peripheral nerves, and brain. The symptoms of FRDA can vary greatly from person to person, but they often include:
- Ataxia: Loss of balance and coordination, which is usually the first symptom noticed [2].
- Cardiac problems: Some people with FA experience cardiac issues, such as hypertrophic cardiomyopathy, which can lead to heart failure [2].
- Weakness and spasticity: As the disease progresses, individuals may experience weakness and stiffness in their muscles, particularly in the arms and legs [3].
Other symptoms of FRDA may include:
- Difficulty with walking and gait: People with FA often have trouble walking and maintaining balance, which can lead to falls and injuries [5].
- Low body mass index (BMI): Individuals with FRDA tend to have a lower BMI than average due to muscle weakness and decreased appetite [6].
- Muscle pain or stiffness: Some people with FA experience muscle pain or stiffness, particularly in the arms and legs [6].
- Dysphagia: Difficulty swallowing can be a symptom of FRDA, making it challenging for individuals to eat and drink normally [6].
It's essential to note that the progression and severity of symptoms can vary significantly from person to person. Some people with FA may experience mild symptoms, while others may have more severe symptoms that impact their daily lives.
References:
[2] - Ataxia, or loss of balance and coordination, is usually the first symptom noticed in Friedreich's ataxia. [3] - Weakness and spasticity are common symptoms of FRDA as the disease progresses. [5] - Difficulty with walking and gait is a hallmark symptom of FRDA. [6] - Low BMI, muscle pain or stiffness, dysphagia, and other symptoms can occur in individuals with FRDA.
Additional Symptoms
- Cardiac problems
- Weakness and spasticity
- Difficulty with walking and gait
- Low body mass index (BMI)
- ataxia
- muscle pain
- dysphagia
Diagnostic Tests
Diagnostic Tests for Friedreich Ataxia
Friedreich ataxia (FRDA) can be diagnosed through a combination of physical examination, medical history, and various diagnostic tests.
- Physical Examination: A thorough physical exam by a neurologist is essential to diagnose FRDA. The healthcare provider will look for difficulty with balance, loss of sensation, absence of reflexes, and signs of other neurological problems [10].
- Genetic Testing: Genetic testing is the main test that can confirm Friedreich’s ataxia. This involves analyzing the FXN gene for GAA repeat expansions or pathogenic sequence variants [2]. Frataxin protein analysis is a quick, cost-effective test method for establishing a diagnosis of FRDA and will detect rare variants [6][9].
- Imaging Scans: Imaging scans such as MRI or CT scan may be ordered to assess areas of the body that may be affected by FA. These tests can help identify atrophic changes in the brain and spinal cord [8].
- Blood Tests: Blood tests may be conducted to rule out other conditions that may cause similar symptoms [5].
- Nerve Conduction Tests: Nerve conduction tests may be performed to assess nerve function and detect any abnormalities [7].
A definitive diagnosis of FRDA can be reached through genetic testing, which is considered the preferred diagnostic test [14]. It's essential to note that a diagnosis of FRDA can have a significant emotional and financial impact on both the person and their family, highlighting the importance of counseling and community resource support.
References: [1] - Not provided in context [2] - Context 2 [3] - Not provided in context [4] - Not provided in context [5] - Context 5 [6] - Context 6 [7] - Context 7 [8] - Context 8 [9] - Context 9 [10] - Context 10 [11] - Not provided in context [12] - Not provided in context [13] - Not provided in context [14] - Context 14
Additional Diagnostic Tests
- Blood Tests
- Physical Examination
- Genetic Testing
- Imaging Scans
- Nerve Conduction Tests
Treatment
Treatment Options for Friedreich Ataxia
Friedreich ataxia, a rare genetic disorder, has no known effective treatment. However, recent advancements have led to the approval of a specific medication for its management.
- Omaveloxolone (Skyclarys): The FDA has approved omaveloxolone as the first and only therapy specifically indicated for Friedreich's ataxia in adults and adolescents aged 16 years and older [
Recommended Medications
- Omaveloxolone (Skyclarys)
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnoses for Friedreich Ataxia
Friedreich ataxia (FA) can be challenging to diagnose due to its similarities with other early-onset, progressive ataxias. The following conditions are often considered in the differential diagnosis of FA:
- Spinocerebellar ataxia types 1, 2, 3, or pure cerebellar ataxia: These autosomal dominant diseases also present with gait and motor difficulties, but they have distinct genetic characteristics.
- Abetalipoproteinemia: A rare inherited disorder that affects the absorption of fats and fat-soluble vitamins, leading to neurological symptoms similar to FA.
- Ataxia with isolated vitamin E deficiency: A condition caused by a deficiency in vitamin E, which can lead to progressive ataxia and other neurological symptoms.
- Dentatorubropallidoluysian atrophy: A rare genetic disorder that affects the brain's motor control systems, leading to progressive ataxia and other movement disorders.
- Hereditary motor and sensory neuropathies: A group of inherited conditions that affect the nerves responsible for motor function and sensation, leading to symptoms similar to FA.
These differential diagnoses are important to consider when evaluating patients with suspected Friedreich ataxia, as they can have overlapping symptoms and require distinct medical management. [1][2][3][4]
In addition to these conditions, other early-onset ataxias such as Charcot-Marie-Tooth type 1 and 2, ataxia-oculomotor apraxia type 1 and 2 may also be considered in the differential diagnosis of FA. [5][6]
Additional Differential Diagnoses
- Ataxia with isolated vitamin E deficiency
- Spinocerebellar ataxia types 1, 2, 3, or pure cerebellar ataxia
- Dentatorubropallidoluysian atrophy
- Hereditary motor and sensory neuropathies
- Charcot-Marie-Tooth type 1 and 2
- ataxia-oculomotor apraxia type 4
- abetalipoproteinemia
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_5542
- owl#annotatedSource
- t374678
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0111219
- core#notation
- DOID:0111219
- oboInOwl#hasDbXref
- MIM:601992
- IAO_0000115
- A Friedreich ataxia that has_material_basis_in mutation in the 9p23-p11 chromosome region.
- oboInOwl#hasExactSynonym
- FRDA2
- rdf-schema#label
- Friedreich ataxia 2
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_12705
- relatedICD
- http://example.org/icd10/G11.11
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.